Clover Health Investments (CLOV)
(Delayed Data from NSDQ)
$2.78 USD
-0.11 (-3.81%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $2.81 +0.03 (1.08%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth B Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CLOV 2.78 -0.11(-3.81%)
Will CLOV be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CLOV based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CLOV
Clover Health Pre-Q2 Earnings Analysis: Buy, Sell or Hold the Stock?
Centene Pulls 2025 Guidance as Marketplace Growth Falters
CLOV: What are Zacks experts saying now?
Zacks Private Portfolio Services
Cigna Expands Coverage With RhinAer & Enhances Rhinitis Treatment
Here's Why MOH Shares Are Attracting Prudent Investors Now
Ensign Enhances Presence With 3 New Acquisitions in 2 States
Other News for CLOV
CLOV Supports Initiative for Unified Healthcare Data Ecosystem
Clover 'supports' White House, CMS' push for simplifying health data access
Novo Nordisk Stock is on Sale- A Cash Flow Giant
Clover Health Investments Corp (CLOV) Announces Key Leadership Appointment at Counterpart ...